Compounds > mitomycin
Page last updated: 2024-08-16

mitomycin and kanamycin a

mitomycin has been researched along with kanamycin a in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hatsu, M; Hotta, K; Imai, S; Ishikawa, J; Mizuno, S; Phomsuwansiri, P; Zhu, CB1
Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K1
TAGUCHI, A1

Reviews

1 review(s) available for mitomycin and kanamycin a

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for mitomycin and kanamycin a

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
PCR inhibition assay for DNA-targeted antibiotics.
    The Journal of antibiotics, 1995, Volume: 48, Issue:11

    Topics: Actinomycetales; Anti-Bacterial Agents; Bacteriophage lambda; Base Sequence; Bleomycin; Culture Media, Conditioned; Cycloserine; DNA; DNA Damage; DNA Primers; DNA, Bacterial; DNA, Viral; Electrophoresis, Agar Gel; Ferrous Compounds; Kanamycin; Mitomycin; Molecular Sequence Data; Polymerase Chain Reaction; Templates, Genetic

1995
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
    FEMS immunology and medical microbiology, 1999, Volume: 26, Issue:2

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2

1999
[BASIC STUDIES ON BONE TISSUE CULTURE AND THE EFFECT OF VARIOUS ANTIBIOTICS ON BONE GROWTH].
    Nihon Seikeigeka Gakkai zasshi, 1963, Volume: 37

    Topics: Anti-Bacterial Agents; Bone and Bones; Bone Development; Chick Embryo; Chloramphenicol; Culture Media; Erythromycin; Kanamycin; Mitomycin; Penicillins; Streptomycin; Tetracycline; Tissue Culture Techniques; Toxicology

1963